Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v2.3.0.15
Consolidated Statements of Operations (Unaudited) (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Revenue:        
Product revenues $ 2,000 $ 0 $ 23,000 $ 0
License revenues 0 0 0 0
TOTAL REVENUE 2,000 0 23,000 0
Cost of Product Revenue 8,000 0 48,000 0
Gross profit (loss) (6,000) 0 (25,000) 0
Operating Expenses:        
Research and development 0 66,000 49,000 160,000
Selling, general and administrative 535,000 588,000 2,806,000 1,810,000
Total operating expenses 535,000 654,000 2,855,000 1,970,000
Loss from Operations (541,000) (654,000) (2,880,000) (1,970,000)
Change in value of warrant and derivative liabilities 681,000 44,000 783,000 59,000
Interest expense/income (117,000) (23,000) (465,000) (422,000)
Total Other Income (Expense) 564,000 21,000 318,000 (363,000)
Income (loss) before provision for income taxes 23,000 (633,000) (2,562,000) (2,333,000)
Provision for income taxes 0 0 0 0
Net income (loss) $ 23,000 $ (633,000) $ (2,562,000) $ (2,333,000)
Earnings (Loss) Per Share, basic and diluted $ 0.00 $ 0.01 $ (0.01) $ (0.02)
Weighted Average Shares Outstanding, basic and diluted 213,511,550 124,506,306 183,038,141 100,054,520